Abstract
Large cell neuroendocrine carcinoma (LCNEC) is a highly malignant cancer originally found in lung in 1991. In extremely rare occasions, primary LCNEC is found in the mediastinum; approximately 40 of such cases have been reported. Due to the limited number of reported cases, a standardized treatment protocol has yet to be established. We report a case of a 66-year-old woman with primary mediastinal LCNEC who presented with superior vena cava syndrome. Emergent radiotherapy was performed, followed by systemic chemotherapy with cisplatin and etoposide, which resulted in a dramatic tumor reduction. This is the first report describing the achievement of a complete response after systemic chemotherapy in a patient with primary LCNEC.
Author supplied keywords
Cite
CITATION STYLE
Hidaka, T., Okuzumi, S., Matsuhashi, A., Takahashi, H., Hata, K., Shimizu, S., & Iwasaki, Y. (2019). Large cell neuroendocrine carcinoma of the mediastinum successfully treated with systemic chemotherapy after palliative radiotherapy. Internal Medicine, 58(4), 563–568. https://doi.org/10.2169/internalmedicine.0437-17
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.